Asian Paints:2,678.50+4.81 (+0.18%)
Cipla:1,440.80-0.43 (-0.03%)
Eicher Motors:7,371.00+10.30 (+0.14%)
Nestle India:1,453.80-9.36 (-0.64%)
Grasim Inds:3,216.40+24.58 (+0.77%)
Hindalco Inds.:970.30+6.84 (+0.71%)
Hind. Unilever:2,150.50+6.00 (+0.28%)
ITC:281.25-0.79 (-0.28%)
Trent:2,901.90-2.32 (-0.08%)
Larsen & Toubro:3,942.20+56.34 (+1.45%)
M & M:3,124.00+38.57 (+1.25%)
Reliance Industries:1,304.60+24.83 (+1.94%)
Tata Consumer:1,106.60-0.11 (-0.01%)
Tata Motors PVeh:335.55+4.04 (+1.22%)
Tata Steel:190.52+2.61 (+1.39%)
Wipro:175.66+2.90 (+1.68%)
Apollo Hospitals:8,780.50-64.57 (-0.73%)
Dr Reddy's Labs:1,246.90-22.60 (-1.78%)
Titan Company:4,574.60+18.68 (+0.41%)
SBI:1,036.10+14.00 (+1.37%)
Shriram Finance:1,042.30+10.63 (+1.03%)
Bharat Electron:413.00+6.78 (+1.67%)
Kotak Mah. Bank:379.35+2.19 (+0.58%)
Infosys:1,071.40+20.60 (+1.96%)
Bajaj Finance:1,015.30+11.54 (+1.15%)
Adani Enterp.:3,152.20+68.46 (+2.22%)
Sun Pharma.Inds.:1,930.80-7.95 (-0.41%)
JSW Steel:1,247.90+22.07 (+1.80%)
HDFC Bank:825.60+8.01 (+0.98%)
TCS:2,076.70+27.26 (+1.33%)
ICICI Bank:1,402.00+21.26 (+1.54%)
Power Grid Corpn:283.25+1.91 (+0.68%)
Maruti Suzuki:13,870.00+141.40 (+1.03%)
Axis Bank:1,320.30+22.71 (+1.75%)
HCL Technologies:1,158.50+8.05 (+0.70%)
O N G C:244.14+0.49 (+0.20%)
NTPC:345.35+1.65 (+0.48%)
Coal India:427.35-2.54 (-0.59%)
Bharti Airtel:1,913.90-17.19 (-0.89%)
Tech Mahindra:1,451.20+24.96 (+1.75%)
Jio Financial:242.07+8.70 (+3.73%)
Adani Ports:1,827.50+27.36 (+1.52%)
HDFC Life Insur.:569.10+17.27 (+3.13%)
SBI Life Insuran:1,849.90+28.24 (+1.55%)
Max Healthcare:1,111.10+9.80 (+0.89%)
UltraTech Cem.:11,664.00+139.45 (+1.21%)
Bajaj Auto:10,127.00-28.44 (-0.28%)
Bajaj Finserv:1,909.50+14.59 (+0.77%)
Interglobe Aviat:5,296.50+66.94 (+1.28%)
Eternal:288.30-4.15 (-1.42%)
Asian Paints:2,678.50+4.81 (+0.18%)
Cipla:1,440.80-0.43 (-0.03%)
Eicher Motors:7,371.00+10.30 (+0.14%)
Nestle India:1,453.80-9.36 (-0.64%)
Grasim Inds:3,216.40+24.58 (+0.77%)
Hindalco Inds.:970.30+6.84 (+0.71%)
Hind. Unilever:2,150.50+6.00 (+0.28%)
ITC:281.25-0.79 (-0.28%)
Trent:2,901.90-2.32 (-0.08%)
Larsen & Toubro:3,942.20+56.34 (+1.45%)
M & M:3,124.00+38.57 (+1.25%)
Reliance Industries:1,304.60+24.83 (+1.94%)
Tata Consumer:1,106.60-0.11 (-0.01%)
Tata Motors PVeh:335.55+4.04 (+1.22%)
Tata Steel:190.52+2.61 (+1.39%)
Wipro:175.66+2.90 (+1.68%)
Apollo Hospitals:8,780.50-64.57 (-0.73%)
Dr Reddy's Labs:1,246.90-22.60 (-1.78%)
Titan Company:4,574.60+18.68 (+0.41%)
SBI:1,036.10+14.00 (+1.37%)
Shriram Finance:1,042.30+10.63 (+1.03%)
Bharat Electron:413.00+6.78 (+1.67%)
Kotak Mah. Bank:379.35+2.19 (+0.58%)
Infosys:1,071.40+20.60 (+1.96%)
Bajaj Finance:1,015.30+11.54 (+1.15%)
Adani Enterp.:3,152.20+68.46 (+2.22%)
Sun Pharma.Inds.:1,930.80-7.95 (-0.41%)
JSW Steel:1,247.90+22.07 (+1.80%)
HDFC Bank:825.60+8.01 (+0.98%)
TCS:2,076.70+27.26 (+1.33%)
ICICI Bank:1,402.00+21.26 (+1.54%)
Power Grid Corpn:283.25+1.91 (+0.68%)
Maruti Suzuki:13,870.00+141.40 (+1.03%)
Axis Bank:1,320.30+22.71 (+1.75%)
HCL Technologies:1,158.50+8.05 (+0.70%)
O N G C:244.14+0.49 (+0.20%)
NTPC:345.35+1.65 (+0.48%)
Coal India:427.35-2.54 (-0.59%)
Bharti Airtel:1,913.90-17.19 (-0.89%)
Tech Mahindra:1,451.20+24.96 (+1.75%)
Jio Financial:242.07+8.70 (+3.73%)
Adani Ports:1,827.50+27.36 (+1.52%)
HDFC Life Insur.:569.10+17.27 (+3.13%)
SBI Life Insuran:1,849.90+28.24 (+1.55%)
Max Healthcare:1,111.10+9.80 (+0.89%)
UltraTech Cem.:11,664.00+139.45 (+1.21%)
Bajaj Auto:10,127.00-28.44 (-0.28%)
Bajaj Finserv:1,909.50+14.59 (+0.77%)
Interglobe Aviat:5,296.50+66.94 (+1.28%)
Eternal:288.30-4.15 (-1.42%)
Arihant Plus App

Arihant Plus App

Remus Pharmaceuticals Ltd

Remus Pharma. |

Market Closed
746.00
1.72 (-0.23%)
As on 10/07/26, 2:11 PM
Market Cap881.15 CR
Current Price₹746
High / Low₹993.95 / 580
PE Ratio45.37
Book Value₹434.4
Dividend Yield0.07%
ROCE21.60%
ROE---
Face Value₹2.00
Current Vol.1,800
Average Vol.---
ISININE0O5T01011
PB Ratio5.15
Debt to Equity0.09
Net Profit Margin6.19
Operating Margin8.17

Share Price Chart - Remus Pharmaceuticals Ltd

+0.00 (+0.00%)6M

Stock Performance

747.75735.05
746
Previous CloseToday's Open
580993.95
746
52W Low52W High
₹735.05Today's Open
₹747.75Previous Close
1,800Volume
₹58052W Low
₹993.9552W High

Ratios

No data available

About Company

  • Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat
  • Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad
  • The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs
  • It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries
  • The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet
  • The core business of the Company into three categories, which comprise of Manufacturing, through loan licencse or on contract manufacturing bassis, of approved finished formulations and distribution of the same in various countries; Trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers
  • The product portfolio comprises of therapeutic drugs like ACE inhibitors, anaesthetic, Anti histamine, Antifungal, Anti-inflammatory, Antibiotic, Antidiabetic, Antipsychotic, Antiretroviral, Chronic Obstructive Pulmonary Disease, Asthma, Carcinoid tumours, CNS stimulants, Nasal decongestants, Potassium deficiency, Probiotic, Antispasmodic, Ocular-hypertension, Urology and Vitamin deficiency
  • The Pharma business operations are supported by various contract manufacturers having facilities which are WHO GMP Compliant
  • The core strength lies in getting approved formulation manufactured through contract manufacturers under loan licence and marketing of formulations through marketing network across geographies
  • The Company incorporated 'Relius Pharmaceuticals SRL' as a new subsidiary Company in Bolivia, effective on October 13, 2023

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI47.72
SMA 20768.35
SMA 50752.68
SMA 100701.38
SMA 200710.69
SMA 10766.78
MACD_12_26_Days6.21
EMA10Day765.67
EMA20Day762.94
EMA50Day743.54
MACD_12_26_9_Days-3.70
EMA100Day727.69
EMA200Day754.49

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth191.33%
ROE18.58%
EBITDA Margin8.17%

All figures in ₹ Crores

Indicators20252024
Revenue
620.36
212.94
Interest
1.46
0.50
Expenses
574.67
183.98
Financing Profit
50.67
31.79
Financing Margin %
8%
15%
Other Income
4.98
2.83
Depreciation
1.87
1.12
Profit before tax
47.34
30.17
Tax %
19%
20%
Net Profit
38.42
24.28
EPS in Rs
65.21
42.97
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
14 Nov 2025
Interim 1 Dividend (₹0.5)
The Board has approved 01st Interim Dividend of Rs. 0.50 (Fifty paise only) per equity share of face value of Rs. 10/- (Rupees Ten only) each fully paid up for the Financial Year 2025-26. The record date for the purpose of payment of Interim Dividend, as intimated earlier will be November 14, 2025.
10 Nov 2025
25 Sept 2025
AGM
AGM
02 Sept 2025
18 Sept 2025
Final Dividend (₹0.5)
The Board has recommended Dividend of Rs. 0.50 (Fifty paise only) per Equity Share of face value of Rs. 10/- (Rupees Ten only) each fully paid up for the Financial Year 2024-25, subject to the approval by shareholders of the Company at the ensuing Annual General Meeting ('AGM'). Remus Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Sep-2025. (As Per NSE Announcement Dated On : 02.09.2025)
17 May 2025
04 Jul 2025
Bonus Issue (1:1)
1:1 Bonus Issue of Equity Shares
30 Jun 2025
20 Nov 2024
Interim Dividend (₹1)
Interim Dividend for FY 2024-25 of 10% i.e., Re. 1.00 per equity share of face value of Rs. 10.00 each. The record date for the purpose of payment of Interim Dividend, as intimated earlier will be November 20, 2024
09 Nov 2024
20 Sept 2024
AGM
AGM
29 Aug 2024
06 Jun 2024
Bonus Issue (3:1)
3:1 Bonus Issue of Equity Shares
04 Jun 2024
21 May 2024
EGM
EGM
23 Apr 2024
02 May 2024
Interim 2 Dividend (₹4)
Remus Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board meeting held on April 23, 2024. Declared 02nd interim dividend of Rs. 04/- (Rupees Four only) per equity share having face alue of Rs. 10/- each for the financial year 2023-24.
23 Apr 2024
13 Mar 2024
EGM
EGM
14 Feb 2024

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
748
881
24
3
22
0
6.19%
1,939
4,65,195
37
6
30
0
19.78%
6,811
1,80,823
69
11
59
0
23.41%
4,897
1,65,725
76
20
50
1
11.09%
1,442
1,16,467
31
3
23
0
9.92%
1,160
1,15,695
21
4
17
0
19.86%
2,503
1,14,441
20
5
16
0
14.56%
1,270
1,05,987
26
3
17
0
12.34%
2,531
1,04,544
52
6
36
0
14.39%
1,587
92,144
26
2
17
0
10.98%
Showing 10 of 134 Results

Frequently Asked Questions

What is Share Price of Remus Pharmaceuticals Ltd?

The current share price of Remus Pharmaceuticals Ltd (Remus Pharma.) is ₹746.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the 52-week high and low of Remus Pharmaceuticals Ltd?

Remus Pharmaceuticals Ltd has a 52-week high of ₹993.95 and a 52-week low of ₹580.00. This range shows the stock's price volatility over the past year.

What is the ROCE of Remus Pharmaceuticals Ltd?

The Return on Capital Employed (ROCE) of Remus Pharmaceuticals Ltd is 21.60%. ROCE measures how efficiently the company generates profits from its capital, indicating management effectiveness.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2